Aug 21 (Reuters) - Carasent ASA CARAS.OL :
* EVIMERIA EMR AB Q2 REVENUE OF SEK 14.8 MILLION, AN
INCREASE OF
42 % AS COMPARED TO Q2 2018
* EVIMERIA EMR AB Q2 EBITDA OF SEK 3,4 MILLION AS COMPARED
TO SEK
2,2 MILLION DURING Q2 2018
* Q2 REVENUE NOK 11.2 MILLION VERSUS NOK 5.8 MILLION YEAR
AGO
* Q2 NET PROFIT NOK 0.3 MILLION VERSUS LOSS NOK 3.0 MILLION
YEAR
AGO
Source text for Eikon: ID:nObiBD1f7a
Further company coverage: CARAS.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))